New drug aimed at stopping breast cancer return after surgery
NCT ID NCT06300411
First seen Feb 23, 2026 · Last updated May 01, 2026 · Updated 10 times
Summary
This early-phase trial tests a new drug called SRG-514, which is applied directly to the area where breast cancer is removed during surgery. The goal is to find the safest dose and see how the body handles it. About 24 adults with breast cancer who are having breast-conserving surgery will take part. The study focuses on safety and side effects, not yet on curing the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Audie Murphy VA
San Antonio, Texas, 78229, United States
-
Duke Cancer Center
Durham, North Carolina, 27710, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo
Rochester, Minnesota, 55905, United States
-
Memorial Health
Savannah, Georgia, 31404, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.